wine + purpose
We encourage you to enjoy our award winning wines responsibly, and charitably.
Award winning wine with a purpose
Our commitment to you is simple: to support prostate cancer research.
The major source of external revenue for The Foundation is through collaboration with our wine making efforts at 2redWinery where we produce award-winning Zinfandels and Syrah/Rhone blends. Your tax-deductible contributions to The Foundation entitles you to our wine as gifts.
Since 2013, the Foundation continued to combine wine-making with fund-raising, rewarding supporters with great wines from the wine library of 2redWinery.
All proceeds support the foundation.
A long-time wine enthusiast of wine, I started small-volume wine making in 2007. The motivation then was indulging a long-time passion and, well, making my own wine. I had some half-baked notions of marketing my wine but had not taken significant steps until more serious matters unfolded.
In 2006 and 2008, I was biopsied by my urologist to evaluate an elevated PSA and was told that “it’s all good!” and to never again check my PSA as it would always be high. In 2009, I diagnosed my own metastatic prostate cancer. In exchange for their failure to diagnose my cancer at a curable stage and for the bad advice, the university medical center provided a small settlement. Determined to make the best, I created The Hollander Foundation and funded it with the settlement.
Wine + Purpose
And that is why we make our wine available through The Hollander Foundation.
The idea to continue to fund The Hollander Foundation with my wine making efforts followed: trying to do good with something I loved.
Or, if you prefer, instead of lemonade from lemons, wine from grapes. And, some pretty excellent wine, at that.
About 220,800 new cases of prostate cancer will be diagnosed this year.
About 27,540 men will die of prostate cancer this year.
1 IN 7
1 IN 7
About 1 man in 7 will be diagnosed with prostate cancer during his lifetime.
Prostate cancer trails only lung cancer in American men as a cause of cancer death.
The odds are that you already know someone who has been affected by prostate cancer.
As of July, 2019, the Foundation continues to operate with a 0.0% overhead. Recipients of unrestricted grants from the Foundation include:
- 2013 – Lance Pagliaro, M.D., Department of Genitourinary Medical Oncology, MD Anderson
- 2014 – Nima Sharifi, M.D., Department of Cancer Biology, Cleveland Clinic
- 2015 – Padmanee Sharma, M.D., Department of Genitourinary Medical Oncology, MD Anderson
- 2016 – Scott Dehm, M.D. Department of Laboratory Medicine and Pathology, Mayo Clinic
- 2017 – Mary-Ellen Taplin, M.D. Department of Medicine, Harvard Medical School
- 2018 – Partnering with Fox Chase Cancer Center
- 2019 – Marc Smaldone – Fox Chase Cancer Center